Molecular Hydrogen for Cognitive Function and Performance in Elderly
- Conditions
- Cognitive ImpairmentsAging
- Interventions
- Other: Molecular Hydrogen
- Registration Number
- NCT02830854
- Lead Sponsor
- University of Novi Sad, Faculty of Sport and Physical Education
- Brief Summary
A variety of non-pharmacological interventions have been used in the management of Alzheimer's disease (AD) and similar cognitive disorders in elderly, yet no therapeutic modality has demonstrated conclusive positive results in terms of effectiveness. Although it is still unknown what triggers AD, recent studies have shown that AD is associated with brain energy depletion, oxidative stress, and mitochondrial dysfunction. Since supplemental molecular hydrogen (H2) supports cell energy production and acts as a highly bioavailable mitochondria-related antioxidant, it may provide an ideal agent to facilitate treatment and perhaps prevention of AD and similar cognitive disorders in elderly. The overall hypothesis to be evaluated in this project is that administration of H2 will positively affect patient-reported outcomes and clinical biomarkers in men and women suffering from AD.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 13
- Age over 65
- No psychiatric comorbidities
- Use of dietary supplements 4 weeks before study commence
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Molecular Hydrogen Molecular Hydrogen Molecular hydrogen: 20 min per day of 3% H2 during 4 weeks
- Primary Outcome Measures
Name Time Method ADAS-Cog score for cognitive function Change from Baseline ADAS-Cog Score at 4 weeks ADAS-Cog total score and scores for 4 separate cognitive domains (memory, orientation, praxis, and language) will be evaluated.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Applied Bioenergetics Lab at Faculty of Sport and PE
🇷🇸Novi Sad, Vojvodina, Serbia